Johnson John Paul 4
4 · Evolent Health, Inc. · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Johnson John Paul
Chief Financial Officer
Transactions
- Award
Class A Common Stock
2024-03-01+12,123→ 236,133 total - Tax Payment
Class A Common Stock
2024-03-01$34.41/sh−11,213$385,839→ 224,920 total - Tax Payment
Class A Common Stock
2024-03-02$34.41/sh−9,020$310,378→ 215,900 total
Footnotes (4)
- [F1]Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- [F2]Securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027.
- [F3]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F4]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.